Recruiting

Multimodal Telerehabilitation

Sponsor:

University of Utah

Code:

NCT07093177

Conditions

Prostate Cancer

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Telerehabilitation Unit

Study Details

Brief summary:

Prostate cancer has a significant impact on patient quality of life (QoL) directly, as well as through the management of localized disease (such as surgery and radiation-related incontinence, erectile dysfunction, and bowel dysfunction), and via direct side effects of androgen deprivation therapy (ADT) resulting in a considerable physical and psychological burden. Recent studies demonstrated the efficacy of multimodal rehabilitation for functional recovery, improvements in QoL, reduction in cancer symptoms, and secondary and tertiary prevention. Despite the mounting evidence regarding the benefits of multimodal rehabilitation for this population, multiple barriers limit the access of prostate cancer survivors to cancer rehabilitation, especially in rural areas.

This study is a pilot study to assess usability, acceptability, and exercise adherence in 12-week multimodal telerehabilitation in patients receiving ADT with either high-risk or metastatic prostate cancer residing in rural areas.

Conditions

Prostate Cancer

Study ID

NCT07093177

Start date

Feb 24, 2026

Status verified date

Apr, 2026

Completion date

Sep, 2028

Anticipated

Primary completion date

Sep, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Age 18 and older
  • Confirmed diagnosis of prostate cancer
  • Men receiving standard-of-care ADT either for high-risk, locally advanced prostate cancer or as a part of multicomponent management of metastatic prostate cancer
  • Residing in a rural community, as indicated by zip code in RUCA areas

Exclusion Criteria:

  • Unstable angina, uncontrolled hypertension, recent myocardial infarction, pacemakers, painful or unstable bony metastases, or recent skeletal fractures
  • Engaged in a regular exercise rehabilitation program
  • Relocation plans within next 3 months
  • Participating in another clinical trial
  • Have a working telephone line in their home or a cell phone.

Study Design

Enrollment

30 participants

Anticipated

Intervention Model

Single group

Primary purpose

Supportive Care

Interventions and Outcome Measures

Arms

experimental: Multimodal Telerehabilitation

Participation in a remote telerehabilitation program for 12 weeks.

Based on the remote physical therapy assessment, a physical therapist will prescribe an individualized rehabilitation plan to each participant. Exercise regimens, lengths of sessions, repetition counts, and frequency of workouts may be tailored depending on individual needs and capabilities.

Interventions

Telerehabilitation Unit

Telerehabilitation is the use of information and communication technology (ICT) to deliver rehabilitation services remotely in participants' homes or other settings. A telerehab unit consists of a touchscreen tablet, a portable bike, elastic bands, and a pulse oximeter. A mobile Wi-Fi hotspot device will be provided for participants who have limited or no internet connection for the duration of the study. The telerehab unit is designed to work in areas with limited internet connectivity as all multimedia materials are stored locally on the tablet.

Primary outcome measure

  • Acceptability [ Time Frame: up to 12-week after initiation of study intervention ]
  • Functional Assessment of Cancer Therapy-Prostate (FACT-P) [ Time Frame: up to 12-week after initiation of study intervention ]

Central Contacts and Locations

Central contacts

Manish Kohli, MD

801-646-4018Manish.Kohli@hci.utah.edu

Locations

Huntsman Cancer Institute at University of Utah

Recruiting

Salt Lake City, Utah, United States, 84112

Contacts

Manish Kohli, MD

801-646-4018Manish.Kohli@hci.utah.edu

Principal Investigator:

Manish Kohli, MD

More Information

Sponsor

University of Utah

Last update posted

Apr 13, 2026

Last verified

Apr, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by University of Utah on 2026-04-13.